Protagonist Therapeutics Inc. (PTGX): Billionaire Tom Steyer Likes Upside Potential of This Stock
AI disclosure
Summary
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has been a consistent feature in the 13F portfolio of Farallon Capital since the fourth quarter of 2017. Back then,...